SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001192482-13-000154
Filing Date
2013-08-01
Accepted
2013-08-01 11:30:57
Documents
1
Period of Report
2013-06-19

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 4945
  Complete submission text file 0001192482-13-000154.txt   7248
Mailing Address 6340 QUADRANGLE DRIVE SUITE 100 CHAPEL HILL NC 27517-8149
Business Address 6340 QUADRANGLE DRIVE SUITE 100 CHAPEL HILL NC 27517-8149 919-313-6617
CEMPRA, INC. (Issuer) CIK: 0001461993 (see all company filings)

IRS No.: 262644445 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address QUAKER BIOVENTURES 2929 ARCH STREET PHILADELPHIA PA 19104
Business Address QUAKER BIOVENTURES 2929 ARCH STREET PHILADELPHIA PA 19104 (215) 988-6800
Quaker BioVentures II LP (Reporting) CIK: 0001497725 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-35405 | Film No.: 131001574

Mailing Address CIRA CENTER 2929 ARCH STREET PHILADELPHIA PA 19104
Business Address CIRA CENTER 2929 ARCH STREET PHILADELPHIA PA 19104 215-988-6800
Quaker BioVentures Capital II, L.P. (Reporting) CIK: 0001583083 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-35405 | Film No.: 131001573